CH5015765 is an orally available Hsp90 inhibitor bound to the N-terminal ATP binding site, with a dissociation constant of 3.4 nM, CH5015765 exerts antiproliferative activity against human cancer cell lines, with IC50 values of 0.46 µM for HCT116 colorectal cancer cells and 0.57 µM for NCI-N87 gastric cancer cells. CH5015765 can be used for the study of cancer[1][2].
Molekulargewicht:
344.82
Reinheit:
98.01
CAS Nummer:
[959766-47-3]
Formel:
C16H13ClN4OS
Target-Kategorie:
HSP
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten